Enphasys is devoted to improving oral drug performance. Our patented invention, the Enabling Absorption Device (ENA) compares performance of any type of advanced drug formulation and correctly picks the top performer in vivo without need for animal experiments. Enphasys cutting edge expertise in drug formulation optimization helps ensure the optimal dosage form is selected for clinical development faster and at lower cost. Enphasys is based in Uppsala and was founded in 2019.
